rs1554803631
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000093.5(COL5A1):c.3233G>A(p.Gly1078Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. G1078G) has been classified as Likely benign.
Frequency
Consequence
NM_000093.5 missense
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.3233G>A | p.Gly1078Glu | missense_variant | Exon 41 of 66 | ENST00000371817.8 | NP_000084.3 | |
| COL5A1 | NM_001278074.1 | c.3233G>A | p.Gly1078Glu | missense_variant | Exon 41 of 66 | NP_001265003.1 | ||
| COL5A1 | XM_017014266.3 | c.3233G>A | p.Gly1078Glu | missense_variant | Exon 41 of 65 | XP_016869755.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A1 | ENST00000371817.8 | c.3233G>A | p.Gly1078Glu | missense_variant | Exon 41 of 66 | 1 | NM_000093.5 | ENSP00000360882.3 | ||
| COL5A1 | ENST00000371820.4 | c.3233G>A | p.Gly1078Glu | missense_variant | Exon 41 of 66 | 2 | ENSP00000360885.4 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 33 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, classic type, 1    Uncertain:1 
This sequence change replaces glycine with glutamic acid at codon 1078 of the COL5A1 protein (p.Gly1078Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with COL5A1-related disease. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236), and missense variants at these glycine residues in COL5A1 are more frequently observed in individuals with disease than in the general population (PMID: 22696272, 23587214). However, the clinical significance of this observation remains uncertain since only a limited number of affected individuals have been described to date. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at